Zantac (Ranitidine) Recalled For Cancer Risk

The FDA has launched Zantac's memory and all ranitidine drug products. The investigation disclosed that ranitidine drugs contain impurities that can lead to an increased risk of cancer. The impurity that has a danger to consumers is n-nitrosodimethylamine or NDMA. 

Daily sources contain low levels of NDMA which are considered safe, from drinking water to meat, fish, and cheese, and certain drugs. Previous testing of ranitidine products, including Zantac, found unsafe NDMA levels forcing drugs manufacturer to launch voluntary withdrawals from affected products. This includes Sanofi, a Zantac manufacturer.

If you or your family members have been diagnosed with cancer after taking Zantac for each time period, we encourage you to contact a free initial consultation. Our Zantac advocates can assess your legal rights and, if you have a claim, we can file a lawsuit against Sanofi on your behalf.

John Bales Attorneys

Image Source: Google

The potential for short-term and long-term effects of taking Zantac varies depending on whether NDMA exposure through the results of the drug in a diagnosis with one of the causes listed above. While some form of cancer has the potential to be fatal, many forms of cancer can be treated. However, even when it is possible to recover with treatment, cancer treatment can have a number of short-term and long-term effects. This includes:

  • Alopecia (hair loss)
  • Anemia (number of low blood cells)
  • Bleeding and bruising
  • Chronic pain
  • Constipation or diarrhea.
  • Fertility problems
  • Fatigue
  • Symptoms like flu
  • Infection
  • Inflammation
  • Lost appetite
  • Memory loss
  • Nausea and vomiting
  • Nerve problems
  • Problems sleep
  • Swelling
  • Urinary control problems and bladder